Just from that description I would think there are some major issues with regards to scale. That's a 2.5 mL "sliver" that is supposed to produce how many times it's weight in protein *and* guarantee secretion of said protein to the circulation so that it reaches a therapeutic level?
And practically, is this any better for the patient than IV infusion? Or is it just a "novel" way of delivery (scale issues aside)?
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.